Source: PR.COM

Press Release: DaVinci Biosciences : DaVinci Biosciences Announces Publication of "Mesenchymal Stem Cells for the Treatment of Arthritis" in the Book Anti-Aging Therapeutics, Volume 17

DaVinci Biosciences, LLC, a company committed to improving the quality of life for those suffering from degenerative diseases, announced today that the Vice President of Research and Development, Rafael Gonzalez's, paper "Mesenchymal Stem Cells for the Treatment of Arthritis" has been published in the book Anti-Aging Therapeutics, Volume 17 on pages 87-92 (Chapter 8). Arthritis affects 37 million U.S. [PR.com]

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100